UPG Founder John Malanca (https://unitedpatientsgroup.com/be_informed_be_well/) interviews Michael Patterson, the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held, developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis.
Watch and listen in as John and Michael discuss the current state of cannabis therapeutics, government regulations, along with medical professional and pharmaceutical interests in consistent dosing and standardized medicine. Additionally, Michael is an internationally recognized speaker, subject matter expert in the global cannabis/hemp/CBD industry, and published author. Michael is a member of the Scientific Advisory Board for Akers Bioscience, a NASDAQ listed biotechnology company.
Most interesting, John and Michael discuss their many philanthropic interests, and Michael Patterson’s support of Tourette’s research and disease management, while being a nationally recognized public speaker and a past Occupational Therapist and Licensed Nursing Home Administrator.
This interview will give you a business perspective of the growing cannabis markets, the caliber of professionals entering the space, answer the many questions surrounding national prohibition and the relevance of cannabis medicine. It doesn’t get much better than this!
VIDEO Podcast can be seen here – https://unitedpatientsgroup.com/podcast/michael-patterson-the-cannabis-industry-in-the-global-economy (https://unitedpatientsgroup.com/?post_type=upg_podcasts&p=56961&preview=true)
source
